Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,653 | 142 | 98.9% |
| Education | $29.99 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $646.22 | 43 | $0 (2024) |
| Lilly USA, LLC | $416.17 | 27 | $0 (2024) |
| Amgen Inc. | $348.78 | 10 | $0 (2024) |
| Dexcom, Inc. | $314.59 | 13 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $161.35 | 10 | $0 (2024) |
| Indivior Inc. | $114.90 | 1 | $0 (2018) |
| Allergan, Inc. | $94.73 | 5 | $0 (2020) |
| PFIZER INC. | $82.46 | 4 | $0 (2023) |
| IDORSIA PHARMACEUTICALS US INC | $65.24 | 4 | $0 (2023) |
| Corcept Therapeutics | $53.62 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $254.54 | 15 | Novo Nordisk Inc ($86.92) |
| 2023 | $368.19 | 20 | Lilly USA, LLC ($88.37) |
| 2022 | $595.18 | 41 | Novo Nordisk Inc ($191.58) |
| 2021 | $898.79 | 41 | DEXCOM, INC. ($252.55) |
| 2020 | $292.66 | 20 | Novo Nordisk Inc ($129.58) |
| 2019 | $50.70 | 4 | Novo Nordisk Inc ($25.01) |
| 2018 | $223.07 | 2 | Indivior Inc. ($114.90) |
All Payment Transactions
143 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.21 | General |
| 09/19/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Endocrinology | ||||||
| 09/10/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: NEUROLOGY | ||||||
| 09/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Oncology | ||||||
| 08/29/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Endocrinology | ||||||
| 08/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Cardio-renal | ||||||
| 08/06/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Endocrinology | ||||||
| 07/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Diabetes | ||||||
| 06/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Diabetes | ||||||
| 03/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Diabetes | ||||||
| 03/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: DIABETES | ||||||
| 03/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Diabetes | ||||||
| 02/21/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.44 | General |
| 01/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: DIABETES | ||||||
| 01/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Inflammation | ||||||
| 11/27/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Diabetes | ||||||
| 11/09/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Diabetes | ||||||
| 11/02/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/31/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.90 | General |
| 10/25/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: INSOMNIA | ||||||
| 10/24/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Diabetes | ||||||
| 09/26/2023 | Relievant Medsystems, Inc. | Intracept (Device), Intracept, Intracept | Food and Beverage | Cash or cash equivalent | $26.30 | General |
| Category: Pain | ||||||
| 09/19/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Oncology | ||||||
| 08/30/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/28/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: INSOMNIA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,271 | 2,484 | $822,971 | $189,309 |
| 2022 | 14 | 1,098 | 2,565 | $877,640 | $192,691 |
| 2021 | 13 | 933 | 2,080 | $751,566 | $167,513 |
| 2020 | 13 | 1,027 | 2,060 | $579,461 | $131,497 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 20 | 41 | $9,061 | $1,254 | 13.8% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 15 | 28 | $2,968 | $678.24 | 22.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 14 | 14 | $2,212 | $531.72 | 24.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 24 | 31 | $1,332 | $298.31 | 22.4% |
| 81002 | Urinalysis, manual test | Office | 2022 | 39 | 44 | $484.00 | $151.21 | 31.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 17 | 49 | $163.17 | $43.91 | 26.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 579 | 1,660 | $646,470 | $143,854 | 22.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 45 | 61 | $33,245 | $8,063 | 24.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 73 | 83 | $22,722 | $4,745 | 20.9% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 21 | 21 | $12,873 | $3,398 | 26.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 36 | 36 | $18,288 | $2,635 | 14.4% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2021 | 34 | 67 | $8,174 | $2,042 | 25.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 53 | 53 | $2,915 | $968.84 | 33.2% |
| 95249 | Continuous monitoring of glucose in tissue fluid using sensor under skin | Office | 2021 | 13 | 13 | $2,184 | $581.10 | 26.6% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 12 | 17 | $1,819 | $473.62 | 26.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 20 | 20 | $1,460 | $329.40 | 22.6% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent | Office | 2021 | 11 | 11 | $656.92 | $219.01 | 33.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 11 | 11 | $462.00 | $111.20 | 24.1% |
| 81002 | Urinalysis, manual test | Office | 2021 | 25 | 27 | $297.00 | $93.96 | 31.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 442 | 1,389 | $455,592 | $97,184 | 21.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 124 | 130 | $23,985 | $9,819 | 40.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 150 | 201 | $45,426 | $9,717 | 21.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 33 | 33 | $11,412 | $3,757 | 32.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 27 | 27 | $13,500 | $2,537 | 18.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 36 | 37 | $4,139 | $1,888 | 45.6% |
About Dr. Richard Avery, DO
Dr. Richard Avery, DO is a Diagnostic Radiology healthcare provider based in Livingston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023073822.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Avery, DO has received a total of $2,683 in payments from pharmaceutical and medical device companies, with $254.54 received in 2024. These payments were reported across 143 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,653).
As a Medicare-enrolled provider, Avery has provided services to 4,329 Medicare beneficiaries, totaling 9,189 services with total Medicare billing of $681,011. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Diagnostic Radiology
- Other Specialties Internal Medicine
- Location Livingston, TX
- Active Since 04/18/2006
- Last Updated 12/29/2022
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1023073822
Products in Payments
- Ozempic (Drug) $309.75
- DEXCOM G6 TRANSMITTER (Device) $252.55
- TRULICITY (Drug) $246.47
- Aimovig (Biological) $210.77
- JARDIANCE (Drug) $171.93
- Rybelsus (Drug) $169.22
- MOUNJARO (Drug) $142.22
- SUBLOCADE (Drug) $114.90
- Otezla (Drug) $105.10
- RYBELSUS (Drug) $96.61
- QUVIVIQ (Drug) $65.24
- Dexcom G6 Transmitter (Medical Supply) $62.04
- Korlym (Drug) $53.62
- Yupelri (Drug) $51.97
- ELIQUIS (Drug) $51.02
- Cologuard Collection Kit (Device) $49.38
- Kerendia (Drug) $47.35
- VRAYLAR (Drug) $44.68
- UBRELVY (Drug) $35.20
- FreeStyle Libre 2 (Device) $33.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Livingston
Lyle Gesner, M.d, M.D
Diagnostic Radiology — Payments: $115,617
Dr. Hannah Kotch, Md, MD
Diagnostic Radiology — Payments: $1,390
Robert Kamieniecki, M.d, M.D
Diagnostic Radiology — Payments: $1,165
David Wilson, M.d, M.D
Diagnostic Radiology — Payments: $823.56
Cornelius Mccarthy, M.d, M.D
Diagnostic Radiology — Payments: $652.93
Linda Sanders, M.d, M.D
Diagnostic Radiology — Payments: $412.87